Skip to main content

Hyperactivity: Drugs

Question for Department of Health and Social Care

UIN 54036, tabled on 23 September 2021

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the waiting time from diagnosis of ADHD to the patient receiving medication.

Answered on

13 December 2021

Clinical commissioning groups and National Health Service trusts should have due regard to the National Institute for Health and Care Excellence’s guideline ‘Attention deficit hyperactivity disorder: diagnosis and management’. This guideline, published in September 2019, aims to improve the diagnosis of ADHD, the quality of care and support that people receive, including access to medication. The guideline does not recommend a maximum waiting time from an individual receiving a diagnosis of ADHD to receiving medication.